Evogene Ltd (EVGN)

Jan 29, 2025

Evogene (NASDAQ:EVGN) Now Covered by Analysts at StockNews.com - Defense World

Jan 29, 2025

Jan 27, 2025

United States Agricultural Biologicals Market Competition - GlobeNewswire

Jan 27, 2025

Jan 27, 2025

United States Agricultural Biologicals Market Competition and Forecasts 2024-2029, Competitive Analysis of BASF, Syngenta Crop Protection, Bayer, Evogene ,Vegalab Inc. - Yahoo Finance UK

Jan 27, 2025

Jan 26, 2025

Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting - GuruFocus.com

Jan 26, 2025

Jan 26, 2025

Monsanto Expands Agreement with Israel’s Evogene - Agribusiness Global

Jan 26, 2025

Jan 25, 2025

Higher R&D costs lead Evogene to loss - גלובס

Jan 25, 2025

Jan 21, 2025

Evogene (NASDAQ:EVGN) Now Covered by StockNews.com - Defense World

Jan 21, 2025

Jan 20, 2025

Evogene Ltd. Announces Conclusion of Employment of Eyal Ronen as Executive Vice President of Business Development, Effective March 4, 2025 - Marketscreener.com

Jan 20, 2025

Jan 15, 2025

Evogene Announces Management Restructuring - TipRanks

Jan 15, 2025

Jan 05, 2025

Evogene (NASDAQ:EVGN) Coverage Initiated by Analysts at StockNews.com - Defense World

Jan 05, 2025

Dec 30, 2024

Evogene Announces Special General Meeting to Approve Share Options for CEO - TipRanks

Dec 30, 2024

Dec 28, 2024

Lavie Bio Announces Expansion of its Bio-Inoculant Product for S - GuruFocus.com

Dec 28, 2024

Dec 28, 2024

Evogene (NASDAQ:EVGN) Earns Sell Rating from Analysts at StockNews.com - Defense World

Dec 28, 2024

Dec 27, 2024

N2OFF (NASDAQ:NITO) and Evogene (NASDAQ:EVGN) Head-To-Head Review - Defense World

Dec 27, 2024

Dec 20, 2024

Evogene Ltd. (NASDAQ:EVGN) Position Lessened by BNP Paribas Financial Markets - Defense World

Dec 20, 2024

Dec 19, 2024

Evogene (NASDAQ:EVGN) vs. N2OFF (NASDAQ:NITO) Financial Review - Defense World

Dec 19, 2024

Dec 18, 2024

Evogene stock touches 52-week low at $1.25 amid market challenges - Investing.com Canada

Dec 18, 2024

Dec 17, 2024

Evogene stock touches 52-week low at $1.25 amid market challenges By Investing.com - Investing.com South Africa

Dec 17, 2024

Dec 16, 2024

Minichromosomal Technology in Agriculture Market Size - openPR

Dec 16, 2024

Dec 13, 2024

Marrone Bio Innovations : Evogene and Marrone Bio Innovations Disclose Positive Results in Insect Control Collaboration - Marketscreener.com

Dec 13, 2024

Dec 10, 2024

Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification - GuruFocus.com

Dec 10, 2024

Dec 07, 2024

Evogene Schedules Second Quarter 2024 Financial Results Release - The Eastern Progress Online

Dec 07, 2024

Dec 06, 2024

Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials - The Eastern Progress Online

Dec 06, 2024

Dec 05, 2024

Evogene stock touches 52-week low at $1.44 amid market challenges - Investing.com Nigeria

Dec 05, 2024

Nov 29, 2024

Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024 - GuruFocus.com

Nov 29, 2024

Nov 27, 2024

Evogene Unit Receives Notice Of Termination Of Licensing Agreement With Corteva For Bio Fungicide Lead Candidates - XM

Nov 27, 2024

Nov 26, 2024

Evogene Q3 2024 Earnings Preview - MSN

Nov 26, 2024

Nov 24, 2024

Ventum Financial Issues Pessimistic Forecast for Evogene (TSE:EVGN) Stock Price - Defense World

Nov 24, 2024

Nov 23, 2024

Evogene Ltd. (NASDAQ:EVGN) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 23, 2024

Nov 22, 2024

Evogene Ltd (EVGN) Q3 2024 Earnings Call Highlights: Navigating Challenges and Seizing Opportunities - Investing.com Canada

Nov 22, 2024

Nov 22, 2024

Evogene Schedules Third Quarter 2024 Financial Results Release - GuruFocus.com

Nov 22, 2024

Nov 21, 2024

Casterra Announces a Key Milestone in its Operational Expansion - GuruFocus.com

Nov 21, 2024

Nov 21, 2024

Evogene Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 21, 2024

Nov 21, 2024

Evogene earnings missed by $0.30, revenue fell short of estimates - Investing.com India

Nov 21, 2024

Nov 21, 2024

Evogene Reports Third Quarter 2024 Financial Results - The Malaysian Reserve

Nov 21, 2024

Nov 21, 2024

Evogene: Q3 Earnings Snapshot - San Antonio Express-News

Nov 21, 2024

Nov 21, 2024

Evogene Sees Revenue Growth and Expands AI Collaboration - TipRanks

Nov 21, 2024

Nov 21, 2024

SEC Form 424B3 filed by Evogene Ltd - Quantisnow

Nov 21, 2024

Nov 19, 2024

Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results - Marketscreener.com

Nov 19, 2024

Nov 15, 2024

Evogene stock hits 52-week low at $1.7 amid market challenges - Investing.com India

Nov 15, 2024

Nov 14, 2024

Evogene (EVGN) Set to Announce Quarterly Earnings on Thursday - Defense World

Nov 14, 2024

Nov 13, 2024

Lavie Bio Announces Commercial Expansion of Yalos As Seed Treatment for Soybean - Agribusiness Global

Nov 13, 2024

Nov 12, 2024

Evogene subsidiary Lavie Bio announces commercial expansion of Yalos treatment - TipRanks

Nov 12, 2024

Nov 10, 2024

Evogene (NASDAQ:EVGN) Coverage Initiated at StockNews.com - Defense World

Nov 10, 2024